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The AsperGenius® assay detects several Aspergillus species and the A. fumigatus Cyp51A mutations TR34/L98H/
T289A/Y121F that are associated with azole resistance. We evaluated its contribution in identifying A. lentulus
and A. felis, 2 rare but intrinsically azole-resistant sibling species within the Aspergillus section Fumigati. Identifi-
cation of these species with conventional culture techniques is difficult and time-consuming. The assay was test-
ed on (i) 2 A. lentulus and A. felis strains obtained from biopsy proven invasive aspergillosis and (ii) control
A. fumigatus (n = 3), A. lentulus (n = 6) and A. felis species complex (n = 12) strains. The AsperGenius® resis-
tance PCR did not detect the TR34 target in A. lentulus and A. felis in contrast to A. fumigatus. Melting peaks for
L98H and Y121F markers differed and those of the Y121F marker were particularly suitable to discriminate the
3 species. In conclusion, the assay can be used to rapidly discriminate A. fumigatus, A. lentulus and A. felis.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Invasive aspergillosis (IA) ismainly caused by A. fumigatus, anAsper-
gillus species in the section Fumigati (Escribano et al., 2013; Neofytos
et al., 2009). When diagnosis is made early and first line therapy with
voriconazole is initiated promptly, a relatively lowmortality is observed
(Marr et al., 2015; Patterson et al., 2016; Slobbe et al., 2008). However,
over the past decade, azole resistance has emerged worldwide and
poses a threat as IA with azole-resistant A. fumigatus is associated with
high mortality of 88% (Chowdhary et al., 2014; van der Linden et al.,
2011; Verweij et al., 2016). Resistance in A. fumigatus is often caused
by 2 mutation combinations (TR34/L98H and TR46/T289A/Y121F) in
the Cyp51A gene that encodes for lanosterol 14α-demethylase, the
target enzyme for azoles (Chowdhary et al., 2014; van der Linden
et al., 2011; Verweij et al., 2016). In addition to IA caused by azole-
resistant A. fumigatus strains, there are also cases caused by species
morphologically similar to A. fumigatus (Alhambra et al., 2008; Coelho
et al., 2011; Escribano et al., 2013; Montenegro et al., 2009; Pelaez et al.,
2013; Zbinden et al., 2012). These so called intrinsic azole-resistant
‘sibling species’ also belong to the Aspergillus section Fumigati and can
be reliable distinguished from A. fumigatus by molecular sequencing.
One of these sibling species was described in 2005 and was named
A. lentulus because of its slow sporulation (Balajee et al., 2005). Subse-
quently, several reports described patients with IA caused by A. lentulus
(Alhambra et al., 2008; Escribano et al., 2013; Gurcan et al., 2013;
Montenegro et al., 2009; Zbinden et al., 2012). The majority of these re-
ported patients died despite treatment. The A. lentulus strains cultured
from these patients had higher minimum inhibitory concentrations
(MICs) for voriconazole, itraconazole, posaconazole, amphotericin-B
and caspofungin in comparison to A. fumigatus. The intrinsic low suscep-
tibility for azoles of A. lentulus can be partly explained by its Cyp51A gene.
This hypothesis is supported by (i) the observation that A. lentulus
without a Cyp51A gene has significantly lower MICs for azoles,
(ii) A. fumigatus transformants harboring the Cyp51A gene of A. lentulus
showed significantly higher MICs than the A. fumigatus wild-type (WT)
strains (Mellado et al., 2011), (iii) Saccharomyces cerevisiae strains
expressing the A. lentulus Cyp51A genewere significantly less susceptible
for azoles than those strains expressing an A. fumigatus Cyp51A gene
(Alcazar-Fuoli et al., 2011). Moreover, three-dimensional models for
the Cyp51A proteins of A. fumigatus and A. lentulus showed that there
are differences in the BC loop that affect the lock-up of voriconazole
(Alcazar-Fuoli et al., 2011). The Cyp51A protein of A. lentulus appears to
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have a reduced affinity for voriconazole and therefore could explain the
reduced susceptibility to azoles in A. lentulus (Alcazar-Fuoli et al., 2011).
Another sibling species in the section Fumigati that sporadically
causes IA is A. felis. To date, only 2 human cases of IA caused by A. felis
have been reported (Coelho et al., 2011; Pelaez et al., 2013). In both
cases, the strains were initially misidentified as A. viridinutans and
later identified as A. felis (Alvarez-Perez et al., 2014; Barrs, 2013).
These strains had high MICs to voriconazole and itraconazole, but low
MICs to posaconazole and caspofungin, and variable MICs to
amphotericin-B (Coelho et al., 2011; Pelaez et al., 2013). The resistance
mechanism of A. felis remains unclear.
The occurrence of IA due to resistant A. fumigatus (sibling) species
warrants emphasis on prompt identification of these infecting species
and their resistance profile. As in vitro drug susceptibility testing is
often not feasible, as cultures remain negative or sibling species fail to
sporulate, molecular techniques are an option. The AsperGenius®
multiplex real-time polymerase chain reaction (PCR) assay detects the
genus Aspergillus, and A. fumigatus and A. terreus to the species level.
In addition, it detects the aforementioned 2 most common mutation
combinations of A. fumigatus that are associated with azole resistance.
The assay has been validated in bronchoalveolar (BAL) fluid and
serum (Chong et al., 2015; Chong et al., 2016; White et al., 2015).
Here, we report 2 patients with proven IA caused by A. lentulus and
A. felis species complex, respectively, and the contribution of the
AsperGenius® assay to their identification.
2. Methods
The AsperGenius® multiplex real-time PCR assay (PathoNostics,
Maastricht, The Netherlands) detects Aspergillus species and mutations
in the Cyp51A gene of A. fumigatus. The assay consists of 2 PCRs: species
PCR and resistance PCR. The species PCR identifies the fungus by
targeting the 28S rRNA multicopy gene. The Aspergillus species probe
detects A. fumigatus, A. terreus, A. flavus and A. niger. The A. fumigatus
probe detects relevant Aspergillus of the section Fumigati. An internal
control is included to monitor for inhibition or manual handling errors.
The resistance PCR targets the single copy Cyp51A gene of A. fumigatus
and detects the TR34, L98H, Y121F and T289Amutations to differentiate
WT from mutant A. fumigatus strains via melting curve analysis. The
resistance PCR does not likely detect and identify species outside the
section Fumigati due to differences in the Cyp51A gene nucleotide
sequence (Mellado et al., 2001).
We first performed the AsperGenius® assay on cultured sibling
strains obtained from the 2 clinical cases to examine (i) if the
resistance PCR yielded (characteristic)melting curves and (ii) if melting
curve analysis could be a tool for interspecies discrimination of
Aspergillus siblings from bothWT andmutant A. fumigatus. In addition
(iii), to assess the precision of the assay, a larger set of strains was
tested: 6 A. lentulus strains and 12 A. felis species complex strains (5 A.
felis, 4 A. parafelis and 3 A. pseudofelis) obtained from the CBS-KNAWFun-
gal Biodiversity Centre (Utrecht, the Netherlands) and the 3 control
A. fumigatus strains (one WT, one TR34/L98H mutant, one TR46/T289A/
Y121F mutant). The assay was performed on the strains in one
experiment. Historical data were used to assess the precision of the
assay for controls. According to the Dutch law on the research on
human subjects (WGBO, art., 458) no informed consent was required
for the use of clinical data from deceased patients.
The spores of the cultured strains were dissolved and 50 microliter
solution was used for DNA extraction. The AsperGenius® assay was
performed according to the manufacturer's instructions. Samples
were processed as BAL pellets (including bead-beating), as described
previously (Chong et al., 2015). The extracted DNA was tested in dupli-
cate and a template control (blank) was included in each run to exclude
contamination. For the species PCR, a sample was considered positive
when one of the duplicates showed fluorescence above the threshold.
For the resistance PCR, the positive control from the assay was used as
a standard for the melting peaks and was tested simultaneously to
determine if the melting peak represents WT or Cyp51A mutations. A
Rotor-Gene Q (Qiagen, Hilden, Germany) instrument was used to per-
form the AsperGenius® assay.
3. Case Reports
3.1. Case Report 1
A68-year-oldmanunderwent an allogeneic hematopoietic stem cell
transplantation (AHSCT) for myelodysplastic syndrome. Fifty-one days
after AHSCT, he was admitted to the hospital because of non-
neutropenic fever and was diagnosed with possible IA according to
criteria of the European Organization for Research and Treatment of
Cancer/Invasive Infectious Diseases Study Mycoses Group (EORTC/
MSG) (De Pauw et al., 2008). Despite antifungal therapy (initially
voriconazole and later liposomal amphotericin-B), he showed no
improvement. As he hadmultiple round lung abnormalitieswith cavita-
tions, a lung biopsy was performed which showed fibrosis with areas of
necrosis with fungal septate hyphae. Its culture revealed Aspergillus
section Fumigati, and was sent to a referral laboratory for further
identification and sensitivity testing. Antifungal therapy was switched
to posaconazole for proven IAwith Aspergillus section Fumigati. Concur-
rently, patient developed severe Graft-versus-host disease and died
90 days post-transplantation. Post-mortem, the isolate was identified
as A. lentulus. Susceptibility testing was performed according to the
clinical breakpoints defined by the European Committee on Antimicro-
bial Susceptibility Testing (EUCAST). The MICs were 2 μg/ml for
amphotericin-B, 2 μg/ml for voriconazole, 0.5 μg/ml for itraconazole
and 0.125 μg/ml for posaconazole, respectively. The strain was de-
posited in the CBS-KNAW Fungal Biodiversity Centre culture collec-
tion (CBS 141342) after confirmation as A. lentulus by sequence
analysis of the internal transcribed spacer (ITS) region, and a part
of the β-tubulin (BenA) and calmodulin (CaM) gene. The generated se-
quences were deposited in GenBank (KX903289, BenA; KX903291,
CaM; KX903293, ITS).
3.2. Case Report 2
A 54-year-old man with a history of pancytopenia and recent use of
high dose prednisolone for relapsed chronic lymphocytic leukemia
(CLL), was diagnosed with probable IA (specific pulmonary lesions and
serum galactomannan of 0.5) according to the revised EORTC/MSG
criteria (De Pauw et al., 2008) and treated with voriconazole. Follow-up
high resolution computed tomography showed that the initial consolida-
tion of the right upper lobe had regressed, but a new pleural mass was
found in the left upper lobe. Biopsy of this mass was performed and
cultured Aspergillus. Because of its poor sporulation, it was not possible
to determine the sensitivity and an A. fumigatus sibling species was
suspected. The isolate was initially identified as A. viridinutans by
sequencing of the BenA gene. As the culture became positive under
voriconazole (no therapeutic drug monitoring performed), the then un-
identifiedAspergillus species,was considered to be azole resistant and an-
tifungal therapywas switched to liposomal amphotericin-B for proven IA.
Despite the switch, patient had fever and developed dyspnea due to pro-
gressive infiltrates. As there were no therapeutic options to treat the pa-
tient for his CLL during an active infection and no improvement was
observed after switching antifungal therapy, treatmentwas discontinued.
Patient died of uncontrolled infection shortly thereafter. Postmortem,
the infecting strain was re-identified as A. felis species complex (CBS
141341) based on sequencing the ITS region, and a part of the
BenA and CaM gene. The generated sequences were deposited in
GenBank (KX903288, BenA; KX903290, CaM; KX903292, ITS). No MICs
were available.
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4. Results
The AsperGenius® assay was performed on strains obtained from
lung biopsy in case report 1 and from pleuralmass biopsy in case report
2. Both strains gave positive signals for the Aspergillus species and
Aspergillus section Fumigati. First, it was examined if the resistance
PCR yielded (characteristic) melting curves (Fig. 1) and melting
temperature (Tm; Table 1) values, respectively, for all Cyp51Amarkers
of the case strains in comparison to A. fumigatus WT and mutants
(TR34/L98H and TR46/T289A/Y121F). The TR34 target was not detected
in the A. lentulus and A. felis species complex strains in contrast to WT
or mutant A. fumigatus. The L98H target showed lower Tm-values for
the A. lentulus and A. felis species complex compared to WT or mutant
A. fumigatus. Comparable Tm-values for the T289A target were found
for A. fumigatus, A. lentulus and A. felis species complex. The Y121F target
showed the most different Tm-values for all 3 sibling species: the Tm
variation was 12.5°C between A. lentulus and A. felis species
complex, 4.0°C between A. fumigatus WT and A. lentulus, and 16.5°C
between A. fumigatus WT and A. felis species complex (Table 1). Thus,
the absent TR34 melting curve with the species specific Y121F melting
curve indicates that melting curve analysis is indeed a tool to discrimi-
nate Aspergillus siblings from both WT and mutant A. fumigatus.
Fig. 1.Melting curves of the resistance PCR on lung biopsy cultures of the 2 sibling species from the cases and control A. fumigatus strains.
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To assess the precision of the findings the melting curves of 6 more
A. lentulus and 12 more A. felis species complex strains were
analyzed next to the 3 control WT and mutant A. fumigatus strains
(Fig. 2). The results of the TR34, T289A and Y121F targets were con-
firmed for all strains tested. However, the Tm-values of the L98H target
were more variable: 3 different Tm-regions were found for A. lentulus
and 2 different Tm-regions for A. felis species complex (Table 2). Based
on the results, again, 2 targets, i.e. TR34 and Y121F can be used to
differentiate the siblings A. lentulus and A. felis species complex from
WT and mutant A. fumigatus.
To evaluate the precision of the Tm-value differences between WT
A. fumigatus, A. lentulus and A. felis, we reviewed Tm-values of 9 other
clinical WT A. fumigatus strains from patients at the Erasmus University
Medical Center that we had previously tested with the AsperGenius®
assay in the period of January 2015 to June 2016. For the L98H target,
the Tm-values of these 9 strains ranged from 60.2°C to 61.7°C,
which overlapped with the A. lentulus and A. felis. However, the
Tm-values of the Y121F target ranged from 62.5°C to 63.3°C and
therefore confirmed that the Tm-values did not overlap with the
Tm-values of the A. lentulus and A. felis species complex strains.
5. Discussion
The results reported here showed that the resistance PCR of the
AsperGenius® assay not only detects the 2most commonmutation com-
binations in the Cyp51A gene of the A. fumigatus that are associated with
azole resistance, but can also be used for interspecies discrimination of
the Aspergillus section Fumigati. Using lung biopsy cultures from 2 pa-
tientswith proven IA, we observed that the resistance PCR showedmelt-
ing curves/Tm-values for A. lentulus and A. felis species complex that
were different from those of A. fumigatusWT or A. fumigatus with TR34/
L98H or TR46/T289A/Y121F mutations. As a result, the resistance PCR
could differentiate A. fumigatus, A. lentulus and A. felis species complex.
These results were confirmed on 18 additional strains.
A. lentulus and A. felis species complex belong to Aspergillus section
Fumigati and can sporadically cause IA. They have often high MICs for
voriconazole (Alhambra et al., 2008; Coelho et al., 2011; Escribano
et al., 2013; Gurcan et al., 2013; Montenegro et al., 2009; Pelaez et al.,
2013; Zbinden et al., 2012). For A. lentulus, its intrinsic low susceptibility
for azoles can be explained partly by its Cyp51A gene (Alcazar-Fuoli
et al., 2011; Mellado et al., 2011). For A. felis species complex, its resis-
tance mechanism is unclear. The current results suggest that the
Cyp51A gene of the A. felis is partly alike that of A. fumigatus as the resis-
tance PCR gives signals for the L98H, T298A and Y121F targets. Given
that voriconazole is the recommended first line therapy for IA
(Patterson et al., 2016), a fast identification of Aspergillus species that
are less susceptible or resistant to voriconazole is important to select
the appropriate antifungal therapy. Currently, identification of the 2
Table 1
Melting temperature (Tm) values of the resistance PCR of A. lentulus, A. felis species com-
plex and wild-type or mutant A. fumigatus strains (controls).
Name Origen Tm values (°C)
TR34 L98H T289A Y121F
A. lentulus strains
CBS 141342 (strain from case 1) Clinical, NL ND 54.0 63.0 59.0
CBS 116884 Environmental,
Korea
ND 54.0 63.0 59.0
CBS 117887 Clinical, USA ND 54.0 63.0 59.0
CBS 117886 Clinical, USA ND 58.0 63.0 59.0
CBS 612.97 Clinical, NL ND 58.0 63.0 59.0
CBS 117884 Clinical, USA ND 61.0 63.0 59.5
CBS 117885 Clinical, USA ND 61.0 63.0 59.0
A. felis species complex strains
CBS 141341 (strain from case 2) Clinical, NL ND 60.5 63.0 46.5
DTO 159-C7 (A. parafelis) Cat, Australia ND 59.0 62.5 46.0
DTO 176-F1 (A. parafelis) Environmental, DE ND 59.0 62.5 46.0
CBS 130245T (A. felis) Cat, Australia ND 60.5 62.5 46.0
CBS 130247 (A. felis) Cat, Australia ND 60.5 62.5 46.0
CBS 130248 (A. felis) Cat, Australia ND 60.5 62.5 46.0
CBS 130249 (A. felis) Cat, Australia ND 60.5 62.5 46.0
CBS 130246 (A. felis) Cat, Australia ND 60.5 62.5 46.0
CBS 130250 (A. pseudofelis) Cat, UK ND 60.0 62.5 48.0
DTO 175-H3 (A. parafelis) Environmental,
Portugal
ND 60.0 62.5 48.0
CBS 140762T (A. parafelis) Clinical, Spain ND 60.0 62.5 48.0
CBS 140766 (A. pseudofelis) Clinical, Spain ND 60.0 62.5 48.0
CBS 140763T (A. pseudofelis) Clinical, Spain ND 60.0 62.5 48.0
A. fumigatus strains (controls)
Wild-type Clinical, NL 64.5 61.5 63.0 63.0
Mutant TR34/L98H Clinical, NL 66.5 65.5 63.0 63.0
Mutant TR46/Y121F/T289A Clinical, NL 64.5 61.5 67.5 68.0
Note: DE, Germany. NL, the Netherlands. UK, United Kingdom. USA, United States of
America. ND, not detected.
Fig. 2. Precision: melting curves of the resistance PCR on the strains provided by the Fungal Biodiversity Centre.
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tested sibling species is challenging for 2 reasons. Firstly, most
patients with IA are culture negative and are diagnosed based on a
positive galactomannan in serum or BAL fluid (Marr et al., 2015). The
value of galactomannan testing for the diagnosis of A. lentulus and
A. felis is unclear as only very few patients with these infections have
been described (Alcazar-Fuoli et al., 2011; Alhambra et al., 2008; Coelho
et al., 2011; Gurcan et al., 2013; Pelaez et al., 2013; Zbinden et al., 2012).
Secondly, if a culture is available, the identification and susceptibility
testing of A. lentulus and A. felis species complex are difficult as they
(i) have slow or poor sporulation and (ii) are morphologically similar
to A. fumigatus except for their inability to grow at 50°C, and (iii) one
or more genes have to be sequenced to confirm their identity (Balajee
et al., 2005; Barrs, 2013). Moreover, this identification process is time
consuming and often has to be performed in a reference laboratory.
The AsperGenius® assay detects several clinical relevant Aspergillus
species and differentiates WT from azole-resistant A. fumigatus directly
on clinical samples, even in culture negative IA (Chong et al., 2015;
Chong et al., 2016). The assay was tested on strains of 2 patients with
proven IA caused by A. lentulus and A. felis species complex. As the
A. fumigatus probe detects these 2 Aspergilli because they are part of
the section Fumigati, we investigated if the resistance PCR could dis-
criminate the siblings from A. fumigatus. This is crucial information, as
one would not want to report a strain as sensitive, when in fact it is re-
sistant to azole treatment (very major error). This would be the case if a
sibling would be identified as ‘A. fumigatus by the A. fumigatus probe’
and sensitive if the resistance PCR of the sibling would conform to the
WTmelting curve. However, the resistance PCRwas able to differentiate
between A. fumigatus, A. lentulus and A. felis species complex. Not all
markers of the resistance PCR were suitable. The T289A marker did
not differentiate between the 3 sibling species. The L98H marker could
differentiate WT A. fumigatus from TR34/L98H mutant control, but was
not able to differentiate A. lentulus or A. felis species complex.
Remarkably, differences were observed in the L98 region between
A. lentulus strains as well as A. felis species complex strains. This is
probably caused by small variations in the L98 sequence region. The
TR34marker showed nomelting curves for A. lentulus and A. felis species
complex in contrast to theWT or mutated A. fumigatus, which is indica-
tive of a sibling species when the L98H probe produces i) a melting
curve and ii) the melting temperature is lower than that of the WT
A. fumigatus (63°C). This is important as the resistance PCR is a single
copy PCR and sometimes the TR34 might not yield a result whereas
the L98H does, which is a known sensitivity issue with low copy
numbers. Most importantly, the Y121F marker clearly differentiated
A. lentulus and A. felis species complex from the WT as well as the
mutant A. fumigatus, and was also able to differentiate between
A. lentulus and A. felis species complex. In other words, the resistance
PCR can aid in preventing to report a very major error (a sibling species
as WT i.e. sensitive to azoles).
The case and control A. fumigatus, A. lentulus and A. felis species com-
plex strains were tested in one experiment. To assess the precision of
this 4°C difference of the Tm-values of the Y121F from A. fumigatus
and A. lentulus, we reviewed historical data and no overlap was
observed. Therefore, when both the melting curve analysis of the TR34
and Y121F markers are analyzed, A. lentulus and A. felis species complex
could be differentiated from the A. fumigatus WT and A. fumigatuswith
TR34/L98H or TR46/T289A/Y121F azole resistance combinations.
In 2014, Sugui et al. published the results of a phylogenetic analysis
on 19 strains from the section Fumigati, of which 9 were A. felis or
A. viridinutans (Sugui et al., 2014).Within these 9 strains, 3 novel species
were distinguished and named A. pseudofelis, A. parafelis and
A. pseudoviridinutans. These novel species showed increased MICs to
itraconazole and voriconazole, which is similar to A. felis (Coelho et al.,
2011; Pelaez et al., 2013; Sugui et al., 2014). The AsperGenius® assay
was tested on 5 A. felis, 4 A. parafelis and 3 A. pseudofelis strains. Due to
the uncertainty of the taxonomy and no clinical consequences regarding
antifungal therapy, we preferred to refer the strains as A. felis species
complex.
There are a few limitations. First, the resistance PCR detects and
identifies polymorphisms in the Cyp51A gene as these polymorphisms
result in different melting curves. However, susceptibility testing on
isolates should be done if possible, to confirm the exact phenotype as
well. However, culture-based susceptibility testing is time consuming
and often impossible with poorly or non-sporulating species like
A. lentulus or A. felis species complex. Secondly, the resistance PCR
was not tested on other siblings in the Fumigati section. To date, the
Aspergillus section Fumigati has up to at least 63 species, of which 17
have been reported to be opportunistic pathogens to humans and/or
other mammals (Frisvad & Larsen, 2015). Except for the A. fumigatus,
the other 16 pathogenic Aspergillus species, of which A. lentulus and
A. felis species complex are among the more ‘frequent’, are described
in case reports or as a very small part of collections of clinical isolates
(Frisvad & Larsen, 2015). We were unable to test if more sibling species
of the section Fumigati would have the same melting curves or Tm-
values as found in the sibling species in this current report. Further
research using the AsperGenius® assay and other sibling species is
therefore needed.
We conclude that the AsperGenius® assay accurately detects and dif-
ferentiates A. fumigatus WT, A. fumigatus TR34/L98H and A. fumigatus
TR46/T289A/Y121F from the sibling species A. lentulus and A. felis species
complex using the azole resistance targets TR34 and Y121F. The absence
of target TR34 indicates A. lentulus or A. felis. Combinedwith Tm-values of
the Y121F target, 59°C indicates A. lentulus, while 46°C indicates A. felis.
Table 2
Melting temperature (Tm) and interspecies differentiation of Aspergilus section Fumigati species with the resistance PCR.




A. lentulus A. felis Conclusion
L98H 61.5
(historical precision of 60.2 to 61.7)
65.5 61.5 54.0/58.0/61.0 59.0/60.5 Differentiation of A. fumigatus TR34/L98H with other
Fumigati species.
Differentiation of A. fumigatus from siblings species
not possible.
TR34 64.5
(historical precision of 63.5 to 65.0)
66.5 64.5 ND ND Differentiation of A. fumigatus TR34/L98H with
A. fumigatus WT.
Absence of TR34 can be indicative for a Fumigati species
combined with L98H Tm value lower than that of
WT (61.5).
T289A 63.0
(historical precision of 62.5 to 63.7)
63.0 67.5 63.0 62.5 Differentiation of A. fumigatus TR46/Y121F/T289A with
other Fumigati species. No differentiation possible of
A. fumigatus wild-type, A. fumigatus
TR34/L98H, A. felis, A. lentulus.
Y121F 63.0
(historical precision of 62.5 to 63.3)
63.0 68.0 59.0 46.0 No differentiation of A. fumigatus WT with A. fumigatus
TR34/L98H.
Differentiation possible of all other Fumigati species.
Note: Tm values are in degrees Celsius. ND, not detected. WT, wild-type.
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A. lentulus and A. felis species complex are often azole resistant. Retro-
spectively, the promptly identification of these 2 sibling species on
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